2012
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
FDA withdraws approval of Avastin for breast cancer
REUTERS HEALTH
Gene markers may make prostate test more accurate
Vinorelbine-trastuzumab combo effective for metastatic breast cancer, less toxic
HRT with estrogen alone protects against breast cancer
Pertuzumab with Herceptin plus chemo can destroy breast tumors
Greater CT coverage improves lung cancer staging
UPDATE: Zoledronic acid ups breast cancer survival in older women
Many U.S. women do not get recommended mammograms
Wait-and-see OK for some mid-risk prostate cancers
Gleevec lets patients live longer after stem cell transplant for PH+ ALL
Elizabeth Edwards, US politician's wife, dies
Early stem cell transplant still important for multiple myeloma
Could aspirin enhance performance of stool DNA test for colon cancer?
Onyx myeloma trial, side effects look favorable
Harms often surface years after cancer drug approval
Novartis drug candidate effective against lymphoma
Refractory Hodgkin's lymphoma responds to new drug
Rituxan delays chemo for slow-growing lymphoma
U.S. advisers reject expanded prostate drug use
NEWS PROVIDED BY
CURE Media Group About Us | Contact Us | CMG Corporate | Cancer Continuum | Press | FAQs | Write for CURE
Advertise Media Kit | Reprints
Manage Subscription Services | Newsletters | Join the CURE Survey Panel | My Account
Legal Licensing | Terms of Use | Privacy Policy
© 2012 CURE Media Group. All rights reserved. SitemapCURE does not provide medical, diagnostic, or treatment advice.